BioUtah News

PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules

PolarityTE announced that it has entered into securities purchase agreements with a single healthcare-focused institutional investor
Civica Selects Profil as Clinical Trial Partner for Affordable Insulin Initiative

Profil has conducted over 30 biosimilar insulin trials and is the leading clinical research organization for studies related…
Biomerics announces expansion in Ireland with a new facility in Galway

BIOMERICS ANNOUNCES EXPANSION INTO IRELAND Expanding High-Performance Balloon Design & Development Capabilities in Galway
Co-Diagnostics, Inc. Completes Principal Design of Test for Monkeypox Virus

Co-Diagnostics announced that it has completed the principal design work of a PCR test for the monkeypox virus…
Biomerics Announces Image Guided Intervention Division

SALT LAKE CITY, UTAH (Monday, May 2, 2022) – Biomerics, a leading vertically integrated contract manufacturer for the…
bioMérieux receives De Novo FDA Authorization for its BIOFIRE® Joint Infection (JI) Panel

Marcy l’Étoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its…
PolarityTE to Effectuate 1-for-25 Reverse Stock Split

PolarityTE announced that the Company will effectuate a 1-for-25 reverse stock split of the Company’s issued and outstanding…
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update

PolarityTE provided a business update and reported financial results for the three-month period ended March 31, 2022.
PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®

PolarityTE announced that the U.S. FDA granted a Regenerative Medicine Advanced Therapy (RMAT) designation to SkinTE under the…
BioHive Takes the Stage at One Utah Summit

The BioHive community was featured prominently at the One Utah Summit held on May 10 at the Grand…
Recursion Co-Founder and CEO, Chris Gibson, Awarded Governor’s Medal for Science and Technology

Recursion Co-founder and CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving…
Recursion CEO, Chris Gibson, Awarded Governor’s Medal for Science and Technology

Recursion CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving the Governor’s…